BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10825145)

  • 21. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
    Rich S; Seelig M; Lee HM; Lin J
    J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New strategies of mammary cancer vaccination.
    Accolla RS; Frangione V; De Lerma Barbaro A; Mortara L
    Breast J; 2010; 16 Suppl 1():S42-4. PubMed ID: 21050309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A poxviral-based cancer vaccine the transcription factor twist inhibits primary tumor growth and metastases in a model of metastatic breast cancer and improves survival in a spontaneous prostate cancer model.
    Kwilas AR; Ardiani A; Dirmeier U; Wottawah C; Schlom J; Hodge JW
    Oncotarget; 2015 Sep; 6(29):28194-210. PubMed ID: 26317648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-based vaccines for the stimulation of immunity to metastatic cancers.
    Ostrand-Rosenberg S; Pulaski BA; Clements VK; Qi L; Pipeling MR; Hanyok LA
    Immunol Rev; 1999 Aug; 170():101-14. PubMed ID: 10566145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.
    Heeg K; Wagner H
    J Immunol; 1995 Jul; 155(1):83-92. PubMed ID: 7602125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma.
    Litton MJ; Dohlsten M; Lando PA; Kalland T; Ohlsson L; Andersson J; Andersson U
    Eur J Immunol; 1996 Jan; 26(1):1-9. PubMed ID: 8566049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cells.
    Tamai H; Watanabe S; Zheng R; Deguchi K; Cohen PA; Koski GK; Shu S
    Clin Immunol; 2008 Apr; 127(1):66-77. PubMed ID: 18262845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells.
    Kabingu E; Vaughan L; Owczarczak B; Ramsey KD; Gollnick SO
    Br J Cancer; 2007 Jun; 96(12):1839-48. PubMed ID: 17505510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel Salmonella Typhi-based immunotherapy promotes tumor killing via an antitumor Th1-type cellular immune response and neutrophil activation in a mouse model of breast cancer.
    Vendrell A; Gravisaco MJ; Pasetti MF; Croci M; Colombo L; Rodríguez C; Mongini C; Waldner CI
    Vaccine; 2011 Jan; 29(4):728-36. PubMed ID: 21095252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonistic effects of the staphylococcal enterotoxin a mutant, SEA(F47A/D227A), on psoriasis in the SCID-hu xenogeneic transplantation model.
    Boehncke WH; Hardt-Weinelt K; Nilsson H; Wolter M; Dohlsten M; Ochsendorf FR; Kaufmann R; Antonsson P
    J Invest Dermatol; 2001 Apr; 116(4):596-601. PubMed ID: 11286628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous effects of B7-1 and B7-2 in the induction of both protective and therapeutic anti-tumor immunity against different mouse tumors.
    Martin-Fontecha A; Cavallo F; Bellone M; Heltai S; Iezzi G; Tornaghi P; Nabavi N; Forni G; Dellabona P; Casorati G
    Eur J Immunol; 1996 Aug; 26(8):1851-9. PubMed ID: 8765031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-angiogenic effects of the superantigen staphylococcal enterotoxin B and bacillus Calmette-Guérin immunotherapy for nonmuscle invasive bladder cancer.
    Reis LO; Ferreira U; Billis A; Cagnon VH; Fávaro WJ
    J Urol; 2012 Feb; 187(2):438-45. PubMed ID: 22177150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ; Dohlsten M; Rosendahl A; Ohlsson L; Søgaard M; Andersson J; Andersson U
    Br J Cancer; 1999 Sep; 81(2):359-66. PubMed ID: 10496366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenovirus-mediated intratumoral lymphotactin gene transfer potentiates the antibody-targeted superantigen therapy of cancer.
    Wang Q; Yu H; Zhang L; Ju D; Pan J; Xia D; Yao H; Zhang W; Wang J; Cao X
    J Mol Med (Berl); 2002 Sep; 80(9):585-94. PubMed ID: 12226740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
    Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
    Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of major histocompatibility complex class II and CD80 by gingival epithelial cells induces activation of CD4+ T cells in response to bacterial challenge.
    Matsuyama T; Kawai T; Izumi Y; Taubman MA
    Infect Immun; 2005 Feb; 73(2):1044-51. PubMed ID: 15664948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases.
    Lewis JD; Shearer MH; Kennedy RC; Bright RK
    Cancer Res; 2005 Apr; 65(7):2938-46. PubMed ID: 15805297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy.
    Frangione V; Mortara L; Castellani P; De Lerma Barbaro A; Accolla RS
    Int J Cancer; 2010 Oct; 127(7):1614-24. PubMed ID: 20091859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.